Truist Securities Downgrades Insulet to Hold, Lowers Price Target to $153
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsDowngradesPrice Target
Truist Securities analyst Richard Newitter downgrades Insulet (NASDAQ:PODD) from Buy to Hold and lowers the price target from $210 to $153.
Truist Securities analyst Richard Newitter downgrades Insulet (NASDAQ:PODD) from Buy to Hold and lowers the price target from $210 to $153.